Product Description
Oral Contraceptive (Sourced from: https://www.clinicaltrials.gov/ct2/show/NCT00544882)
Mechanisms of Action: Unknown
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Duramed Research
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Contraception|Healthy Volunteers
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| DR-DSG-302 | P3 |
Completed |
Healthy Volunteers |
2008-03-31 |
2021-11-19 |
Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments |
|
| DR-DSG-301 | P3 |
Completed |
Contraception |
2007-07-01 |
2019-03-21 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|